Open AccessSelinexor combined with cladribine, cytarabine, and filgrastim in relapsed or refractory acute myeloid leukemia
Author(s) -
Ramzi Abboud,
Ezhilarasi Chendamarai,
Michael P. Rettig,
Kathryn Trinkaus,
Peter A. Riedell,
Camille N. Abboud,
Armin Ghobadi,
Iskra Pusic,
Keith Stockerl-Goldstein,
Mark A. Schroeder,
Ravi Vij,
Peter Westervelt,
John F. DiPersio,
Brian Uy
Publication year - 2019
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2019.236810
Subject(s) - cytarabine , cladribine , medicine , myeloid leukemia , filgrastim , refractory (planetary science) , deoxycytidine , oncology , chemotherapy , neutropenia , biology , astrobiology , gemcitabine